Publications

Nagourney RA, Brewer CA, Radecki S, Kidder WA, Sommers BL, Evans SS, Minor DR, DiSaia PJ. Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. Gynecologic oncology. 2003. PMID: 12504624


Wes Kidder, MD, MPH

Blackstock AW, Tepper JE, Niedwiecki D, Hollis DR, Mayer RJ, Tempero MA. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. International journal of gastrointestinal cancer. 2003. PMID: 15361643


Margaret Tempero, MD

Soumelis V, Scott I, Liu YJ, Levy J. Natural type 1 interferon producing cells in HIV infection. Human immunology. 2002. PMID: 12480265


Jay Levy, MD

Lee TT, Everett DL, Shu HK, Jahan TM, Roach M, Speight JL, Cameron RB, Phillips TL, Chan A, Jablons DM. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. The Journal of thoracic and cardiovascular surgery. 2002. PMID: 12447185


Thierry Jahan, MD

Bok RA, Small EJ. Bloodborne biomolecular markers in prostate cancer development and progression. Nature reviews. Cancer. 2002. PMID: 12459730


Eric Small, MD

Oh WK, Small EJ. Complementary and alternative therapies in prostate cancer. Seminars in oncology. 2002. PMID: 12516040


Eric Small, MD

Tutt A, Ashworth A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends in molecular medicine. 2002. PMID: 12470990


Alan Ashworth, PhD

De Lima M, St John LS, Wieder ED, Lee MS, McMannis J, Karandish S, Giralt S, Beran M, Couriel D, Korbling M, Bibawi S, Champlin R, Komanduri KV. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. British journal of haematology. 2002. PMID: 12437658


Krishna Komanduri, MD

Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer control : journal of the Moffitt Cancer Center. 2002. PMID: 12514564


Pamela Munster, MD

Molldrem JJ, Komanduri K, Wieder E. Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions. Current opinion in hematology. 2002. PMID: 12394172


Krishna Komanduri, MD

Munster PN. Improving breast cancer care. Cancer control : journal of the Moffitt Cancer Center. 2002. PMID: 12514562


Pamela Munster, MD

Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco Md, Dale TC, Smalley MJ. Functional and molecular characterisation of mammary side population cells. Breast cancer research : BCR. 2002. PMID: 12559051


Alan Ashworth, PhD

Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene. 2002. PMID: 12370822


Adil Daud, MD

Rini BI, Small EJ. Hormone-refractory Prostate Cancer. Current treatment options in oncology. 2002. PMID: 12194808


Eric Small, MD

Smaletz O, Scher HI, Small EJ, Verbel DA, McMillan A, Regan K, Kelly WK, Kattan MW. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 12351594


Eric Small, MD

Logan AC, Lutzko C, Kohn DB. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Current opinion in biotechnology. 2002. PMID: 12459333


Aaron Logan, MD, PhD

Logan AC, Lutzko C, Kohn DB. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Current opinion in biotechnology. 2002. PMID: 12459333


Aaron Logan, MD, PhD

Gale M, Blakely CM, Darveau A, Romano PR, Korth MJ, Katze MG. P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stress. Biochemistry. 2002. PMID: 12269832


Collin Blakely, MD, PhD

Herbst RS, Maddox AM, Rothenberg ML, Small EJ, Rubin EH, Baselga J, Rojo F, Hong WK, Swaisland H, Averbuch SD, Ochs J, LoRusso PM. Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 12228201


Eric Small, MD

Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D, Grillo-Lopez A, Shuman MA. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2002. PMID: 12393404


Marc Shuman, MD